Desilles Jean-Philippe, Di Meglio Lucas, Delvoye Francois, Maïer Benjamin, Piotin Michel, Ho-Tin-Noé Benoît, Mazighi Mikael
Interventional Neuroradiology Department and Biological Resources Center, Rothschild Foundation Hospital, Paris, France.
Laboratory of Vascular Translational Science, U1148 INSERM, Paris, France.
Front Neurol. 2022 Jul 6;13:870331. doi: 10.3389/fneur.2022.870331. eCollection 2022.
During the last decade, significant progress has been made in understanding thrombus composition and organization in the setting of acute ischemic stroke (AIS). In particular, thrombus organization is now described as highly heterogeneous but with 2 preserved characteristics: the presence of (1) two distinct main types of areas in the core-red blood cell (RBC)-rich and platelet-rich areas in variable proportions in each thrombus-and (2) an external shell surrounding the core composed exclusively of platelet-rich areas. In contrast to RBC-rich areas, platelet-rich areas are highly complex and are mainly responsible for the thrombolysis resistance of these thrombi for the following reasons: the presence of platelet-derived fibrinolysis inhibitors in large amounts, modifications of the fibrin network structure resistant to the tissue plasminogen activator (tPA)-induced fibrinolysis, and the presence of non-fibrin extracellular components, such as von Willebrand factor (vWF) multimers and neutrophil extracellular traps. From these studies, new therapeutic avenues are in development to increase the fibrinolytic efficacy of intravenous (IV) tPA-based therapy or to target non-fibrin thrombus components, such as platelet aggregates, vWF multimers, or the extracellular DNA network.
在过去十年中,我们对急性缺血性卒中(AIS)情况下血栓的组成和结构有了重大进展。特别是,现在血栓结构被描述为高度异质性,但有两个保留特征:(1)在每个血栓中,核心存在两种不同的主要区域类型,富含红细胞(RBC)区域和富含血小板区域,比例各不相同;(2)围绕核心的外壳仅由富含血小板区域组成。与富含RBC的区域相比,富含血小板的区域高度复杂,主要是这些血栓具有溶栓抵抗性的原因如下:大量存在血小板衍生的纤溶抑制剂、对组织纤溶酶原激活剂(tPA)诱导的纤溶具有抗性的纤维蛋白网络结构改变,以及存在非纤维蛋白细胞外成分,如血管性血友病因子(vWF)多聚体和中性粒细胞胞外陷阱。基于这些研究,正在开发新的治疗途径,以提高基于静脉注射(IV)tPA治疗的纤溶效果,或靶向非纤维蛋白血栓成分,如血小板聚集体、vWF多聚体或细胞外DNA网络。